View all trials
Are you a member? Sign in above to view additional information
  • Study title
    A Phase 1/2 Study of Valproate in Combination withInterferon alpha in Relapsed, Recurrent or Progressive Neuroblastoma
  • Protocol ID
    ACCT003
  • Disease
    Disease Type Disease Subtype
    Solid tumours
    Neuroblastoma
  • Eligibility criteria
  • Study Status
    Open
  • Location(s)
    Children's Hospital at Westmead
    • Centre Study Status:
      Open
    • Notes:
    John Hunter Children's Hospital
    • Centre Study Status:
      Open
    • Notes:
    Lady Cilento Children's Hospital
    • Centre Study Status:
      Open
    • Notes:
    Princess Margaret Hospital
    • Centre Study Status:
      Open
    • Notes:
    Sydney Children's Hospital
    • Centre Study Status:
      Open
    • Notes:
    Women and Children's Hospital
    • Centre Study Status:
      Open
    • Notes:
  • Phase
    Phase 1/2
  • Study type
    Treatment
  • Diagnosis stage
    Relapse/refractory
  • Study open date
    01/04/2010
  • Study close date
    N/A
  • Study chair
    Dr David Ziegler
  • Sponsor
    Australian and New Zealand Children's Haematology Oncology Group
Back to search results